AT
RMD icon

Arlington Trust’s ResMed RMD Stock Holding History

Arlington Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
74
– – ﹤0.01% 423
2026
Q1 		$16.6K Buy
74
+34
+85% +$8.47K ﹤0.01% 357
2025
Q4 		$9.63K Hold
40
– – ﹤0.01% 314
2025
Q3 		$10.9K Hold
40
– – ﹤0.01% 476
2025
Q2 		$10.3K Hold
40
– – ﹤0.01% 485
2025
Q1 		$8.95K Buy
+40
New +$9.34K ﹤0.01% 516

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Arlington Trust's RMD Position: Q2 2026 in Review

Arlington Trust held its ResMed (RMD) position steady in Q2 2026 at 74 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #423.

Arlington Trust first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $16.6K in Q1 2026. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Arlington Trust held 74 shares of ResMed worth $14.4K as of Q2 2026.
  • Arlington Trust left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #423 holding.
  • Arlington Trust first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Arlington Trust's ResMed position peaked at $16.6K in Q1 2026.
  • 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.